claimed that the percentage and absolute count of TIM-3+ PD-1+ CD4+ T cells and TIM-3+ PD-1+ CD8+ T cells were positively correlated with advanced clinical stages for CLL patients. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.